Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kovanaze vs Articaine for Maxillary Anesthesia
NCT04104789Phase 2Withdrawn
- Sponsor
- Virginia Commonwealth University
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
A Phase 2 trial of tetracaine HCl + oxymetazoline HCl in dental caries, apical periodontitis (AP), sponsored by Virginia Commonwealth University. Planned start Sep 2020; status: withdrawn.
02
Drugs
tetracaine HCl + oxymetazoline HCl
03
Conditions
dental cariesapical periodontitis (AP)
Beyond the preview
Go deeper on NCT04104789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04104789.